Marshall Wace

Marshall Wace’s CRISPR Therapeutics CRSP Stock Holding History

Marshall Wace’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-393,295	Closed	-$13.4M	–	2780
2025 Q1	$13.4M	Buy	+393,295	New	+$16.7M	0.02%	664
2024 Q3	–	Sell	-186,591	Closed	-$10.1M	–	2581
2024 Q2	$10.1M	Buy	+186,591	New	+$10.8M	0.01%	727
2024 Q1	–	Sell	-3,200	Closed	-$200K	–	2514
2023 Q4	$200K	Sell	3,200 -132,747	-98%	-$7.34M	﹤0.01%	1979
2023 Q3	$6.17M	Sell	135,947 -321,061	-70%	-$16.6M	0.01%	795
2023 Q2	$25.7M	Buy	+457,008	New	+$25.9M	0.06%	393
2022 Q4	–	Sell	-10,893	Closed	-$712K	–	3020
2022 Q3	$712K	Buy	+10,893	New	+$789K	﹤0.01%	2574
2021 Q4	–	Sell	-255,727	Closed	-$28.6M	–	3942
2021 Q3	$28.6M	Buy	+255,727	New	+$32.1M	0.14%	182
2020 Q2	–	Sell	-1,917	Closed	-$81K	–	1611
2020 Q1	$81K	Sell	1,917 -457	-19%	-$23.6K	﹤0.01%	1359
2019 Q4	$145K	Buy	+2,374	New	+$130K	﹤0.01%	1403
2018 Q2	–	Sell	-4,627	Closed	-$212K	–	724
2018 Q1	$212K	Buy	+4,627	New	+$191K	0.01%	514

Other funds holding CRSP

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Sumitomo Mitsui Trust Group

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return